Literature DB >> 8575846

Cancer mortality in relatives of women with ovarian cancer: the OPCS Study. Office of Population Censuses and Surveys.

D F Easton1, F E Matthews, D Ford, A J Swerdlow, J Peto.   

Abstract

Mortality from cancer and other causes in first-degree relatives of women with ovarian cancer diagnosed before age 60 has been examined in a large population-based cohort study in England and Wales. Relatives of 1,188 ovarian-cancer cases diagnosed between 1954 and 1981 were identified through a register of households established in 1939. Some 4,111 first-degree relatives living in the same household and having the same surname as the index case were followed up through national records until the end of 1992. Over this period, 1,950 deaths (including 574 cancer deaths) occurred in the relatives. Mortality rates within the cohort were compared with age-, sex- and period-adjusted mortality rates for England and Wales. Mortality from ovarian cancer in first-degree relatives was significantly raised (SMR 223, 95% CI 155-310) although the excess was smaller than that found in case-control studies. The SMR increased with decreasing age of the relative, though not with decreasing age of the index case. After allowing for age, sisters of cases had higher ovarian-cancer mortality than mothers (sister:mother SMR ratio 1.89, p = 0.06). The SMR was greater in individuals having 2 first-degree relatives with ovarian cancer (4 deaths versus 0.17 expected, SMR 242). Relatives of ovarian cancer cases also had significantly increased mortality from cancers of the stomach (SMR 146, 69 deaths) and rectum (SMR 150, 33 deaths), and increased mortality from colon cancer, breast cancer and pancreatic cancer which failed to reach statistical significance. Individuals having a relative with colorectal cancer and a relative with ovarian cancer showed a high mortality from both cancers (11 colorectal-cancer deaths versus 1.23 expected, 4 ovarian-cancer deaths versus 0.66 expected.

Entities:  

Mesh:

Year:  1996        PMID: 8575846     DOI: 10.1002/(SICI)1097-0215(19960126)65:3<284::AID-IJC2>3.0.CO;2-W

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  Mutation analysis of the BRCA1 gene in 23 families with cases of cancer of the breast, ovary, and multiple other sites.

Authors:  F Durocher; P Tonin; D Shattuck-Eidens; M Skolnick; S A Narod; J Simard
Journal:  J Med Genet       Date:  1996-10       Impact factor: 6.318

2.  Familial breast cancer genetic testing in the West of Ireland.

Authors:  T P McVeigh; R Irwin; N Cody; N Miller; T McDevitt; K J Sweeney; A Green; M J Kerin
Journal:  Ir J Med Sci       Date:  2013-07-26       Impact factor: 1.568

Review 3.  The genetic epidemiology of breast cancer genes.

Authors:  Deborah Thompson; Douglas Easton
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-07       Impact factor: 2.673

4.  Contribution of the Defective BRCA1, BRCA2 and CHEK2 Genes to the Familial Aggregation of Breast Cancer: a Simulation Study Based on the Swedish Family-Cancer Database.

Authors:  Justo Lorenzo Bermejo; Alfonso García Pérez; Kari Hemminki
Journal:  Hered Cancer Clin Pract       Date:  2004-11-15       Impact factor: 2.857

5.  BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancer.

Authors:  M C Southey; A A Tesoriero; C R Andersen; K M Jennings; S M Brown; G S Dite; M A Jenkins; R H Osborne; J A Maskiell; L Porter; G G Giles; M R McCredie; J L Hopper; D J Venter
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

6.  The rate of the 6174delT founder Jewish mutation in BRCA2 in patients with non-colonic gastrointestinal tract tumours in Israel.

Authors:  A Figer; L Irmin; R Geva; D Flex; J Sulkes; A Sulkes; E Friedman
Journal:  Br J Cancer       Date:  2001-02       Impact factor: 7.640

7.  Sibling risks in cancer: clues to recessive or X-linked genes?

Authors:  K Hemminki; P Vaittinen; C Dong; D Easton
Journal:  Br J Cancer       Date:  2001-02-02       Impact factor: 7.640

Review 8.  Estimating the referral rate for cancer genetic assessment from a systematic review of the evidence.

Authors:  C Featherstone; A Colley; K Tucker; J Kirk; M B Barton
Journal:  Br J Cancer       Date:  2007-01-29       Impact factor: 7.640

9.  Segregation analysis of epithelial ovarian cancer in Finland.

Authors:  A Auranen; L Iselius
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

10.  Cancer incidence in the first-degree relatives of ovarian cancer patients.

Authors:  A Auranen; E Pukkala; J Mäkinen; R Sankila; S Grénman; T Salmi
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.